David Healy – Page 3 – Alliance for Human Research Protection

October 26, 2006

Credibility Crisis: Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA

Credibility Crisis:Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA Thu, 16 Dec

Credibility Crisis: Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA

October 26, 2006

Featured News

AHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D Fri, 9 Dec

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D

October 26, 2006

FDA Strong Drug Ties-Less Monitoring – UK MHRA

FDA Strong Drug Ties-Less Monitoring – UK MHRA Mon, 6 Dec 2004 A front page article in

FDA Strong Drug Ties-Less Monitoring – UK MHRA

October 26, 2006

AHRP Opposes Drug Implants for Psychiatric Patients

AHRP Opposes Drug Implants for Psychiatric Patients Those promoting the implants focus on its delivery of continuous

AHRP Opposes Drug Implants for Psychiatric Patients

October 26, 2006

Eli Lilly Prozac Documents: What do They Reveal?

Eli Lilly Prozac Documents: What do They Reveal? Thu, 27 Jan 2005 A report in the BMJ

Eli Lilly Prozac Documents: What do They Reveal?

October 26, 2006

Black Box Warnings for Antidepressants – What’s Next?

Black Box Warnings for Antidepressants – What’s Next? Thu, 16 Sep 2004 NY TIMES Quotations of the

Black Box Warnings for Antidepressants – What’s Next?

October 26, 2006

Research Protection for Children

AHRP Campaign to Protect Children from Harm Oct 15: FDA Orders Black Box Warnings on Antidepressants labels

Research Protection for Children

October 26, 2006

Dr. David Healy Addresses Credibility Crisis-at Columbia University Oct. 20

Additional information as of late Wed Oct 19: Although I was assured that attendance for a presentation

Dr. David Healy Addresses Credibility Crisis-at Columbia University Oct. 20

October 26, 2006

FDA Asks Antidepressant drug companies to add Cautions on labels

FDA Asks Antidepressant drug companies to add Cautions on labels Mon, 22 Mar 2004 The FDA has

FDA Asks Antidepressant drug companies to add Cautions on labels

October 26, 2006

Dr. Healy – Testing Psychotropic Drugs in Children

Testing Psychotropic Drugs in Children April 30, 2002 David Healy, MD University of Wales College of Medicine

Dr. Healy – Testing Psychotropic Drugs in Children

October 26, 2006

Antidepressant Makers Withhold Data on Children – Washington Post

Antidepressant Makers Withhold Data on Children – Washington Post Thu, 29 Jan 2004 A front page article

Antidepressant Makers Withhold Data on Children – Washington Post

October 26, 2006

Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – Leo

Reply to the American College of Neuropharmacology’s Report on SSRI and Suicidal Behavior in Children Jonathan Leo,

Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – Leo

October 26, 2006

What Parents Aren’t Being told about their Kids Antidepressants – A Suicide Side-Effect? – SF Chronicle

What Parents Aren’t Being told about their Kids Antidepressants – A Suicide Side-Effect? – SF Chronicle Sat,

What Parents Aren’t Being told about their Kids Antidepressants – A Suicide Side-Effect? – SF Chronicle

Load More Articles

ALLIANCE FOR HUMAN RESEARCH PROTECTION

Credibility Crisis: Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA

Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D

FDA Strong Drug Ties-Less Monitoring – UK MHRA

AHRP Opposes Drug Implants for Psychiatric Patients

Eli Lilly Prozac Documents: What do They Reveal?

Black Box Warnings for Antidepressants – What’s Next?

Research Protection for Children

Dr. David Healy Addresses Credibility Crisis-at Columbia University Oct. 20

FDA Asks Antidepressant drug companies to add Cautions on labels

Dr. Healy – Testing Psychotropic Drugs in Children

Antidepressant Makers Withhold Data on Children – Washington Post

Reply to the ACNP’s Report on SSRI and Suicidal Behavior in Children – Leo

What Parents Aren’t Being told about their Kids Antidepressants – A Suicide Side-Effect? – SF Chronicle

Subscribe to Our Newsletter!